Cases & Deals

ADOCIA completes €31.9 million private placement of new shares

Clients ADOCIA

Jones Day advised ADOCIA, a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins, in connection with its €31.9 million (US$34.4 million) private placement of new shares to U.S. and European investors.